Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer - ScienceDirect
Exploring the inhibitory mechanism of resorcinylic isoxazole amine NVP- AUY922 towards the discovery of potential heat shock protein 90 (Hsp90) inhibitors - ScienceDirect
The Anticancer Drug AUY922 Generates a Proteomics Fingerprint That Is Highly Conserved among Structurally Diverse Hsp90 Inhibitors | Journal of Proteome Research
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models | Breast Cancer Research | Full Text
Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants* - Molecular & Cellular Proteomics
Luminespib (NVP-AUY922) | ≥99%(HPLC) | Selleck | HSP (HSP90) inhibitor
The HSP90 Inhibitor, AUY-922, Ameliorates the Development of Nitrogen Mustard-Induced Pulmonary Fibrosis and Lung Dysfunction in
Hsp90 phase II candidate | Vernalis Research
Luminespib - an overview | ScienceDirect Topics
Proteomics Fingerprints of Auy922 and 17-dmag Indicate Common Mechanisms of Action for Hsp90 Inhibitors
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
Hsp90 phase II candidate | Vernalis Research
Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells | Anticancer Research
![PDF] Ganetespib: research and clinical development | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25a520c1fa08e8bd4ed3d065bbaddb983055dc78/2-Table1-1.png "PDF] Ganetespib: research and clinical development | Semantic Scholar")
PDF] Ganetespib: research and clinical development | Semantic Scholar
Frontiers | Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
Targeting HSP90 by the Novel Inhibitor NVP-AUY922 Reduces Growth and Angiogenesis of Pancreatic Cancer | Anticancer Research
Sponsor Novartis Generic Drug Name Alpelisib/BYL719 and AUY922 Trial Indication(s) Advanced or metastatic gastric cancer (GC) ca
Selected structures of Hsp90 inhibitors in clinical trials. | Download Scientific Diagram
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer - Journal of Thoracic Oncology
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer | PGPM
Examples of Hsp90 N-terminal inhibitors in clinical trials. | Download Scientific Diagram
Full article: Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
NVP-AUY922 inhibits downstream signaling of IGF-1Rβ and exerts... | Download Scientific Diagram
The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage | PLOS ONE
Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
